Karyopharm Therapeutics (NASDAQ: KPTI)

Worst CEO, CFO, Legal Counsel in Biotech, in my opinion

This page has been moved to: https://www.rezamusic.com/writings/law-ethics/KPTI-Mismanagement

Also see CGTX due diligence page: https://www.rezamusic.com/health/cognition-therapeutics-cgtx

Google Sites

Report abuse